Total Visits

Views
A phase II, open-label, neoadjuvant, randomized study of LCL161 with paclitaxel in patients with triple-negative breast cancer (TNBC)77

Select a period of time:

Views

Views
April 20253
May 20254
June 20259
July 202521
August 20250
September 20250
October 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States15
Brazil7
Turkey3
United Kingdom2
South Africa2
Argentina2
Barbados1
Canada1
Colombia1
Spain1
 

Top cities views

Views
Istanbul2
Abington1
Ananindeua1
Angers1
Ankara1
Belo Horizonte1
Cleveland1
Clovis1
Compton1
Council Bluffs1